מדיטבין 200 מ"ג

البلد: إسرائيل

اللغة: العبرية

المصدر: Ministry of Health

العنصر النشط:

GEMCITABINE AS HYDROCHLORIDE 200 MG/VIAL

متاح من:

MEDISON PHARMA LTD

ATC رمز:

L01BC05

الشكل الصيدلاني:

POWDER FOR SOLUTION FOR INFUSION

طريقة التعاطي:

I.V

المصنعة من قبل:

INTAS PHARMACEUTICALS LTD, INDIA

المجموعة العلاجية:

GEMCITABINE

الخصائص العلاجية:

Palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-FU refractory pancreatic cancer. Gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. Breast cancer: Gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated. Ovarian cancer: Gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.

تاريخ الترخيص:

2012-11-01